A review of current therapeutics targeting the mitochondrial protease ClpP in diffuse midline glioma, H3 K27-altered
2023 · Neuro-Oncology · 29 citations
https://doi.org/10.1093/neuonc/noad144
R
Ryan J. Duchatel
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
174
Papers
808
Citations
16
h-index
18
i10-index
Ryan J. Duchatel is an academic researcher from Hunter Medical Research Institute. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Cancer, Hypoxia, and Metabolism & ATP Synthase and ATPases Research. The author has an h-index of 16, co-authored 148 publications.
ORCID: 0000-0002-3651-7672Papers by this author
worksBlockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies
2023 · Science Signaling · 22 citations
https://doi.org/10.1126/scisignal.abp9586
Current status and advances to improving drug delivery in diffuse intrinsic pontine glioma
2024 · Journal of Controlled Release · 18 citations
https://doi.org/10.1016/j.jconrel.2024.05.018
Additional file 2 of Correction to: Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22619141
Additional file 2 of Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection
2023 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.22607053
Supplementary Data from ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma
2024 · 0 citations
https://doi.org/10.1158/0008-5472.27027764
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat